Drug Profile
Research programme: alendronic acid derivatives - Merck & Co
Alternative Names: Alendronate derivatives - Merck & CoLatest Information Update: 30 Mar 2010
Price :
$50
*
At a glance
- Originator Merck & Co
- Class
- Mechanism of Action Bone resorption factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 12 Jul 2006 Preclinical trials in Osteoporosis in USA (PO)